[
  {
    "ts": "2025-07-02T18:12:12+00:00",
    "headline": "GE HealthCare Technologies (NasdaqGS:GEHC) Board Confirms US$0.04 Dividend for Q2 2025",
    "summary": "GE HealthCare Technologies (NasdaqGS:GEHC) recently reaffirmed its commitment to shareholder value with a cash dividend declaration, supplemented by a modest rise of 8% in its share price last month. Though not extraordinary, the dividend affirmation would have added a positive weight alongside broader market trends. Despite the turbulence of being removed from several indices, the company's progress in securing FDA approval for expanded applications of its imaging products marks an...",
    "url": "https://finance.yahoo.com/news/ge-healthcare-technologies-nasdaqgs-gehc-181212817.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "69a26ad5-fb17-3db3-89e2-feb838e86d72",
      "content": {
        "id": "69a26ad5-fb17-3db3-89e2-feb838e86d72",
        "contentType": "STORY",
        "title": "GE HealthCare Technologies (NasdaqGS:GEHC) Board Confirms US$0.04 Dividend for Q2 2025",
        "description": "",
        "summary": "GE HealthCare Technologies (NasdaqGS:GEHC) recently reaffirmed its commitment to shareholder value with a cash dividend declaration, supplemented by a modest rise of 8% in its share price last month. Though not extraordinary, the dividend affirmation would have added a positive weight alongside broader market trends. Despite the turbulence of being removed from several indices, the company's progress in securing FDA approval for expanded applications of its imaging products marks an...",
        "pubDate": "2025-07-02T18:12:12Z",
        "displayTime": "2025-07-02T18:12:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vLi2clQ39cq4H4GDgg1AAA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hLmZY7hCIZ66l74wpB8KIg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ge-healthcare-technologies-nasdaqgs-gehc-181212817.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ge-healthcare-technologies-nasdaqgs-gehc-181212817.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GEHC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]